Mast cell activation syndrome
|
(Mast cell activation disorders, SAMA)
Relatively new entity (first published in 2007). Immune pathology in which mast cells inappropriately and excessively release the chemical mediators contained in their granules [histamine, heparin, prostaglandins, Platelet Activating Factor, angiotensin-converting enzyme, leukotrienes, proteolytic enzymes, cytokines, TNF alpha]. This causes chronic and/or recurrent symptoms, including anaphylactic shock or similar conditions. Unlike mastocytosis, where patients have an increased number of mast cells, patients with SAMA have a normal number of these cells, but these are defined as "hyperreactive".
The causes are:
The main symptoms can fluctuate in their type, severity and duration. Many manifestations and symptoms are the same as those of mastocytosis.
Common symptoms are:
Symptoms can be caused or aggravated by triggers, which vary widely and are specific.
Common triggering factors are:
Treatment: mainly symptomatic
Anesthetic implications:
increased risk of anaphylactic reaction; although no cases of anesthetic management have been described, it is sound to apply the same recommendations as in case of mastocytosis (see this term).
References :
Updated: September 2021